NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
December 11, 2025 — TransCode Therapeutics partners with Quantum Leap to test TTX-MC138 in a Phase 2a trial for colorectal cancer patients at high risk of recurrence, targeting minimal residual disease.
December 11, 2025 — GeoVax responds to new recombinant Mpox strain with accelerated GEO-MVA vaccine program. EMA guidance allows direct Phase 3 trial for first US-made Mpox/smallpox vaccine.
December 11, 2025 — American Heart Association warns cuffless blood pressure devices like smartwatches lack accuracy for medical diagnosis. Learn why validation is crucial for hypertension care.
December 11, 2025 — Dr. Roz Kamani recommends fall for Lumecca IPL laser in Vancouver to address summer sun damage with fewer sessions and greater comfort at Kitsilano Medical Aesthetics.
December 11, 2025 — Innova Orthodontics in Coquitlam explains 6 key signs you need an orthodontist, from jaw pain to chewing issues. Learn why early care prevents serious oral health problems.
December 11, 2025 — Brain-computer interface technology is revolutionizing medicine by restoring movement and communication for paralyzed patients. Learn how BCIs work and their ethical implications in this comprehensive review.
December 11, 2025 — ADAP Advocacy's new campaign reveals 340B program failures, with hospitals pocketing drug discounts instead of providing charity care to low-income patients.
December 11, 2025 — AmeriWell Clinics names Dr. Samuel Christian as Medical Director, enhancing integrated care with his 30+ years in surgery and holistic wellness across 14 locations in DC, MD, VA.
December 10, 2025 — HeartBeam receives FDA clearance for 12-lead ECG synthesis software enabling remote cardiac monitoring. The cable-free technology transforms arrhythmia assessment outside clinical settings.
December 10, 2025 — NextPlat Corp reports strong healthcare business growth with over 12,000 new prescriptions expected. Chairman Rodney Barreto leads expansion through contracts and acquisitions.
December 10, 2025 — Soligenix advances HyBryte™ for rare disease treatment as federal policies evolve. Learn about its impact on aging America and biotech innovation in this feature.
December 10, 2025 — HeartBeam receives FDA clearance for revolutionary 3D ECG technology enabling remote cardiac monitoring. Portable device synthesizes 12-lead ECGs for arrhythmia assessment outside medical facilities.
December 10, 2025 — Washington University research shows chemotherapy timing improves brain cancer outcomes. CNS Pharmaceuticals developing novel therapies. TinyGems reports on medical innovation.
December 10, 2025 — GeoVax expands Scientific Advisory Board with global vaccine experts to advance multi-antigen vaccines for immunocompromised patients and underserved populations. Learn about their COVID-19 and oncology trials.
December 10, 2025 — New study finds women with uterine fibroids have 81% higher heart disease risk. Research published in Journal of American Heart Association shows elevated risk persists for 10 years.
December 10, 2025 — McGill University medical students win top awards at 2025 American Osler Society meeting, showcasing excellence in medical humanities research and scholarship programs.
December 10, 2025 — UAE's Next MasterMind Awards 2025 honored leaders in healthcare, aesthetics & tech. Event featured keynote speeches, Lifetime Achievement awards & launched the MasterMind Unfiltered podcast.
December 9, 2025 — TNT's German-made CLEAR WHEY Protein expands to U.S., offering athletes a refreshing, easy-to-digest alternative to traditional milky protein shakes with 81% whey isolate.
December 9, 2025 — Caring Brands completes $4M public offering and uplists to Nasdaq, funding wellness products like hair loss and eczema treatments. Learn about its growth and BioMedWire coverage.
December 9, 2025 — Tonix Pharmaceuticals appoints Irina Ishak as General Counsel to support commercialization and pipeline growth, including fibromyalgia therapy TONMYA and diverse biotech developments.